86 results
Page 4 of 5
6-K
EX-99.1
fhgg0oq2hmk3g4
29 Mar 19
Current report (foreign)
6:16am
6-K
EX-99.1
65wg886t2
29 Mar 19
Current report (foreign)
6:02am
6-K
EX-99.1
qg2yytllq43wyg5v
29 Mar 19
Current report (foreign)
6:00am
6-K
EX-99.1
iddqv802hri3kxl sjsl
7 Jan 19
Current report (foreign)
7:29am
6-K
EX-99.1
46khcp1594wq2g
18 Dec 18
Current report (foreign)
6:07am
6-K
EX-99.1
tmga tjjwal2
28 Nov 18
Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis
6:00am
6-K
EX-99.2
uoelqoz6degzktstw6
26 Oct 18
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
4:19pm
6-K
EX-99.1
pq0pwv
23 Oct 18
Positive Trial Results with Filgotinib In Psoriatic Arthritis and Ankylosing Spondylitis Both Published In the Lancet
7:59am
6-K
EX-99.1
8o4x67mqlsb13
22 Oct 18
Phase 3 Data on Filgotinib In Biologic-experienced Rheumatoid Arthritis to Be Presented at 2018 Acr/arhp Annual Meeting
6:05am
6-K
EX-99.1
k7tbpsgt878zl4we3ow
24 Sep 18
Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients
6:05am
424B5
kalplhsw9u4bl
13 Sep 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
nkym62ehar87ybel7ere
2 Aug 18
Current report (foreign)
4:03pm
6-K
EX-99.1
b28pnm3p5t4b7k8pb1q9
27 Jun 18
Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis patients
6:01am
6-K
EX-99.1
siarp1gy5vdh86
22 May 18
GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS
6:00am
6-K
EX-99.2
v7uqmg
27 Apr 18
Galapagos reports first quarter 2018 results
12:00am
6-K
EX-3.1
6sg784o b9wi18kb
18 Apr 17
Galapagos announces launch of proposed public offering
12:00am